$REGN REGENERON PHARMACEUTICALS, INC. Insider Trading Week 35/2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REGENERON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in REGENERON PHARMACEUTICALS, INC. in week 35/2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 03 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 591.50 | 18 | 10,647 | 28,443 | 28.5 K to 28.4 K (-0.06 %) |
| Sep 03 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 600.30 | 2 | 1,201 | 28,461 | 28.5 K to 28.5 K (-0.01 %) |
| Sep 03 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 601.13 | 20 | 12,023 | 28,463 | 28.5 K to 28.5 K (-0.07 %) |
| Sep 03 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 602.33 | 10 | 6,023 | 28,483 | 28.5 K to 28.5 K (-0.04 %) |
| Sep 03 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 605.62 | 10 | 6,056 | 28,493 | 28.5 K to 28.5 K (-0.04 %) |
| Sep 03 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 608.69 | 20 | 12,174 | 28,503 | 28.5 K to 28.5 K (-0.07 %) |
| Sep 03 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 616.74 | 20 | 12,335 | 28,523 | 28.5 K to 28.5 K (-0.07 %) |
| Aug 31 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Option Exercise | M | 52.03 | 4,000 | 208,120 | 0 | |
| Aug 31 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Option Exercise | M | 52.03 | 6,000 | 312,180 | 4,000 | |
| Aug 31 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Sell | S | 615.04 | 4,672 | 2,873,467 | 14,438 | 19.1 K to 14.4 K (-24.45 %) |
| Aug 31 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Payment of Exercise | F | 614.87 | 2,131 | 1,310,288 | 19,110 | 21.2 K to 19.1 K (-10.03 %) |
| Aug 31 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Buy | M | 52.03 | 4,000 | 208,120 | 21,241 | 17.2 K to 21.2 K (+23.20 %) |
| Aug 31 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Payment of Exercise | F | 614.87 | 3,197 | 1,965,739 | 17,241 | 20.4 K to 17.2 K (-15.64 %) |
| Aug 31 2020 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Buy | M | 52.03 | 6,000 | 312,180 | 20,438 | 14.4 K to 20.4 K (+41.56 %) |
| Aug 31 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 614.51 | 1,900 | 1,167,569 | 54,415 | 56.3 K to 54.4 K (-3.37 %) |
| Aug 31 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 613.54 | 1,100 | 674,894 | 56,315 | 57.4 K to 56.3 K (-1.92 %) |
| Aug 31 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 612.27 | 2,000 | 1,224,540 | 57,415 | 59.4 K to 57.4 K (-3.37 %) |
| Aug 31 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 611.38 | 1,400 | 855,932 | 59,415 | 60.8 K to 59.4 K (-2.30 %) |
| Aug 31 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 610.45 | 3,600 | 2,197,620 | 60,815 | 64.4 K to 60.8 K (-5.59 %) |
| Aug 31 2020 | REGN | REGENERON PHARMACE ... | POON CHRISTINE A | Director | Option Exercise | M | 33.42 | 15,000 | 501,300 | 0 | |
| Aug 31 2020 | REGN | REGENERON PHARMACE ... | POON CHRISTINE A | Director | Option Exercise | M | 25.45 | 25,000 | 636,250 | 0 | |
| Aug 31 2020 | REGN | REGENERON PHARMACE ... | POON CHRISTINE A | Director | Sell | S | 603.20 | 693 | 418,018 | 1,433 | 2.1 K to 1.4 K (-32.60 %) |
| Aug 31 2020 | REGN | REGENERON PHARMACE ... | POON CHRISTINE A | Director | Sell | S | 602.39 | 12,899 | 7,770,229 | 2,126 | 15 K to 2.1 K (-85.85 %) |
| Aug 31 2020 | REGN | REGENERON PHARMACE ... | POON CHRISTINE A | Director | Sell | S | 601.53 | 8,011 | 4,818,857 | 15,025 | 23 K to 15 K (-34.78 %) |
| Aug 31 2020 | REGN | REGENERON PHARMACE ... | POON CHRISTINE A | Director | Sell | S | 600.44 | 12,490 | 7,499,496 | 23,036 | 35.5 K to 23 K (-35.16 %) |
| Aug 31 2020 | REGN | REGENERON PHARMACE ... | POON CHRISTINE A | Director | Sell | S | 599.67 | 5,730 | 3,436,109 | 35,526 | 41.3 K to 35.5 K (-13.89 %) |
| Aug 31 2020 | REGN | REGENERON PHARMACE ... | POON CHRISTINE A | Director | Sell | S | 598.91 | 177 | 106,007 | 41,256 | 41.4 K to 41.3 K (-0.43 %) |
| Aug 31 2020 | REGN | REGENERON PHARMACE ... | POON CHRISTINE A | Director | Buy | M | 25.45 | 25,000 | 636,250 | 41,433 | 16.4 K to 41.4 K (+152.13 %) |
| Aug 31 2020 | REGN | REGENERON PHARMACE ... | POON CHRISTINE A | Director | Buy | M | 33.42 | 15,000 | 501,300 | 16,433 | 1.4 K to 16.4 K (+1,046.76 %) |